Cargando…

Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems

BACKGROUND: Molecular stratification of bladder cancer has revealed gene signatures differentially expressed across tumor subtypes. While these signatures provide important insights into subtype biology, the transcriptional regulation that governs these signatures is not well characterized. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eriksson, Pontus, Aine, Mattias, Veerla, Srinivas, Liedberg, Fredrik, Sjödahl, Gottfrid, Höglund, Mattias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446831/ https://www.ncbi.nlm.nih.gov/pubmed/26008846 http://dx.doi.org/10.1186/s12920-015-0101-5

Ejemplares similares

Molecular subtype classification of urothelial carcinoma in Lynch syndrome
por: Therkildsen, Christina, et al.
Publicado: (2018)

Molecular classification of urothelial carcinoma: global mRNA classification versus tumour‐cell phenotype classification
por: Sjödahl, Gottfrid, et al.
Publicado: (2017)

Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma
por: Aine, Mattias, et al.
Publicado: (2015)

Biological determinants of bladder cancer gene expression subtypes
por: Aine, Mattias, et al.
Publicado: (2015)

HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts
por: Eriksson, Pontus, et al.
Publicado: (2017)

Molecular pathology of the luminal class of urothelial tumors
por: Bernardo, Carina, et al.
Publicado: (2019)

A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort
por: Marzouka, Nour-al-dain, et al.
Publicado: (2018)

Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer—A Narrative Review
por: Sjödahl, Gottfrid, et al.
Publicado: (2022)

DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status
por: Lauss, Martin, et al.
Publicado: (2012)

Recurring urothelial carcinomas show genomic rearrangements incompatible with a direct relationship
por: Marzouka, Nour-Al-Dain, et al.
Publicado: (2020)

Detailed Analysis of Focal Chromosome Arm 1q and 6p Amplifications in Urothelial Carcinoma Reveals Complex Genomic Events on 1q, and SOX4 as a Possible Auxiliary Target on 6p
por: Eriksson, Pontus, et al.
Publicado: (2013)

Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma
por: Sjödahl, Gottfrid, et al.
Publicado: (2019)

Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing: A Systematic Review
por: Medle, Benjamin, et al.
Publicado: (2022)

A comparison of rule-based and centroid single-sample multiclass predictors for transcriptomic classification
por: Eriksson, Pontus, et al.
Publicado: (2021)

A Systematic Study of Gene Mutations in Urothelial Carcinoma; Inactivating Mutations in TSC2 and PIK3R1
por: Sjödahl, Gottfrid, et al.
Publicado: (2011)

Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma
por: Lindgren, David, et al.
Publicado: (2012)

Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors
por: Heidenblad, Markus, et al.
Publicado: (2008)

Analysis of promoter regions of co-expressed genes identified by microarray analysis
por: Veerla, Srinivas, et al.
Publicado: (2006)

Urodrill - a novel MRI-guided endoscopic biopsy technique to sample and molecularly classify muscle-invasive bladder cancer without fractionating the specimen during transurethral resection
por: Eriksson, Pontus, et al.
Publicado: (2023)

The Urothelial Transcriptomic Response to Interferon Gamma: Implications for Bladder Cancer Prognosis and Immunotherapy
por: Baker, Simon C., et al.
Publicado: (2022)

Genome-wide transcription factor binding site/promoter databases for the analysis of gene sets and co-occurrence of transcription factor binding motifs
por: Veerla, Srinivas, et al.
Publicado: (2010)

Independent component analysis reveals new and biologically significant structures in micro array data
por: Frigyesi, Attila, et al.
Publicado: (2006)

Low Frequency of Intratumor Heterogeneity in Bladder Cancer Tissue Microarrays
por: Jakobsson, Lovisa, et al.
Publicado: (2018)

SRIQ clustering: A fusion of Random Forest, QT clustering, and KNN concepts
por: Karlström, Jacob, et al.
Publicado: (2022)

Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
por: Olah, Csilla, et al.
Publicado: (2022)

Immunohistochemical Assays for Bladder Cancer Molecular Subtyping: Optimizing Parsimony and Performance of Lund Taxonomy Classifiers
por: Hardy, Céline S.C., et al.
Publicado: (2022)

Non-Negative Matrix Factorization for the Analysis of Complex Gene Expression Data: Identification of Clinically Relevant Tumor Subtypes
por: Frigyesi, Attila, et al.
Publicado: (2008)

Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma
por: Lu, Huan, et al.
Publicado: (2020)

Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men
por: Teleka, Stanley, et al.
Publicado: (2022)

An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells
por: Holm, Karolina, et al.
Publicado: (2016)

Diagnostic and prognostic implications of a three‐antibody molecular subtyping algorithm for non‐muscle invasive bladder cancer
por: Jackson, Chelsea L, et al.
Publicado: (2021)

Robust assignment of cancer subtypes from expression data using a uni-variate gene expression average as classifier
por: Lauss, Martin, et al.
Publicado: (2010)

Perturbation and stability of PAM50 subtyping in population-based primary invasive breast cancer
por: Veerla, Srinivas, et al.
Publicado: (2023)

FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation
por: Foth, Mona, et al.
Publicado: (2018)

Identification and validation of molecular subtypes’ characteristics in bladder urothelial carcinoma based on autophagy-dependent ferroptosis
por: Liu, Shiwei, et al.
Publicado: (2023)

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
por: Kamoun, Aurélie, et al.
Publicado: (2019)

Recurrent and multiple bladder tumors show conserved expression profiles
por: Lindgren, David, et al.
Publicado: (2008)

Human Leukocyte Antigen‐Based Risk Stratification in Heart Transplant Recipients—Implications for Targeted Surveillance
por: Nilsson, Johan, et al.
Publicado: (2019)

Clinical value of anoikis-related genes and molecular subtypes identification in bladder urothelial carcinoma and in vitro validation
por: Dong, Ying, et al.
Publicado: (2023)

Molecular classification of urothelial bladder carcinoma
por: Schwarzova, Lucia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f05k5u9k7kve9eq4jieoj03lj7